Member, Boston Harbour Angels
Henry is an active member of two angel investing groups, Boston Harbor Angels and Sky Ventures. He retired from Boston Scientific Corporation in 2006, where he was responsible for strategic planning and supplementing internal R&D through identification and assessment of external investment and acquisition opportunities. Henry has 35 years of experience in the medical industry in roles which included R&D, international marketing, regulatory affairs, and strategic planning for major pharmaceutical companies, including Schering-Plough, American Home Products, Sterling Drug and Allergan. He is a fellow of the Royal Society of Medicine and serves on the boards of several start-up health care companies and three Canadian medical device companies.
Connect with Henry: https://www.linkedin.com/in/henry-kay-94b6aa